Misplaced Pages

ACVR2A
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 3Q4T, 3SOC, 4ASX
Identifiers
Aliases	ACVR2A, ACTRII, ACVR2, activin A receptor type 2A
External IDs	OMIM: 102581; MGI: 102806; HomoloGene: 20391; GeneCards: ACVR2A; OMA:ACVR2A - orthologs
Gene location (Human) Chr. Chromosome 2 (human) Band 2q22.3-q23.1 Start 147,844,517 bp End 147,930,826 bp
Gene location (Mouse) Chr. Chromosome 2 (mouse) Band 2 C1.1|2 28.38 cM Start 48,704,121 bp End 48,793,281 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in buccal mucosa cell hair follicle oocyte skin of thigh testicle skin of abdomen lactiferous duct ganglionic eminence tendon Achilles tendon Top expressed in trigeminal ganglion olfactory tubercle subiculum anterior amygdaloid area medial ganglionic eminence epithelium of lens triceps brachii muscle tail of embryo genital tubercle nucleus accumbens More reference expression data BioGPS n/a
Gene ontology Molecular function transferase activity nucleotide binding protein kinase activity PDZ domain binding growth factor binding coreceptor activity activin binding metal ion binding kinase activity protein self-association protein serine/threonine kinase activity transmembrane receptor protein serine/threonine kinase activity inhibin binding protein binding activin-activated receptor activity ATP binding BMP receptor activity transforming growth factor beta-activated receptor activity transforming growth factor beta receptor activity, type II type I transforming growth factor beta receptor binding SMAD binding Cellular component cytoplasm integral component of membrane inhibin-betaglycan-ActRII complex membrane receptor complex plasma membrane integral component of plasma membrane cell surface activin receptor complex Biological process positive regulation of protein phosphorylation male gonad development ejaculation positive regulation of erythrocyte differentiation positive regulation of bone mineralization phosphorylation positive regulation of pathway-restricted SMAD protein phosphorylation gastrulation with mouth forming second penile erection regulation of nitric-oxide synthase activity cellular response to BMP stimulus Sertoli cell proliferation BMP signaling pathway embryonic skeletal system development regulation of BMP signaling pathway protein phosphorylation determination of left/right symmetry transmembrane receptor protein serine/threonine kinase signaling pathway positive regulation of activin receptor signaling pathway positive regulation of osteoblast differentiation regulation of signal transduction spermatogenesis mesoderm development anterior/posterior pattern specification positive regulation of transcription by RNA polymerase II activin receptor signaling pathway transforming growth factor beta receptor signaling pathway pattern specification process Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 92 11480 Ensembl ENSG00000121989 ENSMUSG00000052155 UniProt P27037 P27038 RefSeq (mRNA) NM_001278579 NM_001278580 NM_001616 NM_007396 RefSeq (protein) NP_001265508 NP_001265509 NP_001607 NP_031422 Location (UCSC) Chr 2: 147.84 – 147.93 Mb Chr 2: 48.7 – 48.79 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Activin receptor type-2A is a protein that in humans is encoded by the ACVR2A gene. ACVR2A is an activin type 2 receptor.

Function

This gene encodes activin A type II receptor. Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases.

Interactions

ACVR2A has been shown to interact with:

• ACVR1B,
• INHBA, and
• SYNJ2BP.

References

1. ^ GRCh38: Ensembl release 89: ENSG00000121989 – Ensembl, May 2017
2. ^ GRCm38: Ensembl release 89: ENSMUSG00000052155 – Ensembl, May 2017
3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
5. Donaldson CJ, Mathews LS, Vale WW (May 1992). "Molecular cloning and binding properties of the human type II activin receptor". Biochem. Biophys. Res. Commun. 184 (1): 310–6. doi:10.1016/0006-291X(92)91194-U. PMID 1314589.
6. Bondestam J, Horelli-Kuitunen N, Hildén K, Ritvos O, Aaltonen J (April 2000). "Assignment of ACVR2 and ACVR2B the human activin receptor type II and IIB genes to chromosome bands 2q22.2-->q23.3 and 3p22 and the human follistatin gene (FST) to chromosome 5q11.2 by FISH". Cytogenet. Cell Genet. 87 (3–4): 219–20. doi:10.1159/000015429. PMID 10702675. S2CID 36135054.
7. ^ "Entrez Gene: ACVR2A activin A receptor, type IIA".
8. Lebrun JJ, Takabe K, Chen Y, Vale W (January 1999). "Roles of pathway-specific and inhibitory Smads in activin receptor signaling". Mol. Endocrinol. 13 (1): 15–23. doi:10.1210/mend.13.1.0218. PMID 9892009. S2CID 26825706.
9. De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ (May 1996). "Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors". Exp. Cell Res. 224 (2): 323–34. doi:10.1006/excr.1996.0142. PMID 8612709.
10. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W (March 2000). "Betaglycan binds inhibin and can mediate functional antagonism of activin signalling". Nature. 404 (6776): 411–4. Bibcode:2000Natur.404..411L. doi:10.1038/35006129. PMID 10746731. S2CID 4393629.
11. Martens JW, de Winter JP, Timmerman MA, McLuskey A, van Schaik RH, Themmen AP, de Jong FH (July 1997). "Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells". Endocrinology. 138 (7): 2928–36. doi:10.1210/endo.138.7.5250. PMID 9202237.
12. Tsuchida K, Nakatani M, Matsuzaki T, Yamakawa N, Liu Z, Bao Y, Arai KY, Murakami T, Takehara Y, Kurisaki A, Sugino H (October 2004). "Novel factors in regulation of activin signaling". Mol. Cell. Endocrinol. 225 (1–2): 1–8. doi:10.1016/j.mce.2004.02.006. PMID 15451561. S2CID 34666659.
13. Matsuzaki T, Hanai S, Kishi H, Liu Z, Bao Y, Kikuchi A, Tsuchida K, Sugino H (May 2002). "Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway". J. Biol. Chem. 277 (21): 19008–18. doi:10.1074/jbc.M112472200. PMID 11882656.

External links

• Human ACVR2A genome location and ACVR2A gene details page in the UCSC Genome Browser.

Further reading

• Welt CK (2002). "The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction". Curr. Opin. Obstet. Gynecol. 14 (3): 317–23. doi:10.1097/00001703-200206000-00012. PMID 12032389. S2CID 44327401.
• Matzuk MM, Bradley A (1992). "Cloning of the human activin receptor cDNA reveals high evolutionary conservation". Biochim. Biophys. Acta. 1130 (1): 105–8. doi:10.1016/0167-4781(92)90472-C. PMID 1311955.
• Mathews LS, Vale WW (1991). "Expression cloning of an activin receptor, a predicted transmembrane serine kinase". Cell. 65 (6): 973–82. doi:10.1016/0092-8674(91)90549-E. PMID 1646080. S2CID 36407277.
• Xu J, McKeehan K, Matsuzaki K, McKeehan WL (1995). "Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism". J. Biol. Chem. 270 (11): 6308–13. doi:10.1074/jbc.270.11.6308. PMID 7890768.
• Attisano L, Cárcamo J, Ventura F, Weis FM, Massagué J, Wrana JL (1993). "Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors". Cell. 75 (4): 671–80. doi:10.1016/0092-8674(93)90488-C. PMID 8242742. S2CID 25408172.
• Peng C, Huang TH, Jeung EB, Donaldson CJ, Vale WW, Leung PC (1993). "Expression of the type II activin receptor gene in the human placenta". Endocrinology. 133 (6): 3046–9. doi:10.1210/endo.133.6.8243335. PMID 8243335.
• De Winter JP, De Vries CJ, Van Achterberg TA, Ameerun RF, Feijen A, Sugino H, De Waele P, Huylebroeck D, Verschueren K, Van Den Eijden-Van Raaij AJ (1996). "Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors". Exp. Cell Res. 224 (2): 323–34. doi:10.1006/excr.1996.0142. PMID 8612709.
• Attisano L, Wrana JL, Montalvo E, Massagué J (1996). "Activation of signalling by the activin receptor complex". Mol. Cell. Biol. 16 (3): 1066–73. doi:10.1128/mcb.16.3.1066. PMC 231089. PMID 8622651.
• Liu QY, Niranjan B, Gomes P, Gomm JJ, Davies D, Coombes RC, Buluwela L (1996). "Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells". Cancer Res. 56 (5): 1155–63. PMID 8640777.
• Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K (1996). "Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5". J. Biol. Chem. 271 (35): 21345–52. doi:10.1074/jbc.271.35.21345. PMID 8702914.
• Lebrun JJ, Vale WW (1997). "Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation". Mol. Cell. Biol. 17 (3): 1682–91. doi:10.1128/mcb.17.3.1682. PMC 231893. PMID 9032295.
• Macías-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL (1998). "Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2". J. Biol. Chem. 273 (40): 25628–36. doi:10.1074/jbc.273.40.25628. PMID 9748228.
• Barbara NP, Wrana JL, Letarte M (1999). "Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily". J. Biol. Chem. 274 (2): 584–94. doi:10.1074/jbc.274.2.584. PMID 9872992.
• Lux A, Attisano L, Marchuk DA (1999). "Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1". J. Biol. Chem. 274 (15): 9984–92. doi:10.1074/jbc.274.15.9984. PMID 10187774.
• D'Abronzo FH, Swearingen B, Klibanski A, Alexander JM (1999). "Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors". J. Clin. Endocrinol. Metab. 84 (5): 1716–21. doi:10.1210/jcem.84.5.5704. PMID 10323406.
• Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (1999). "Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation". J. Cell Sci. 112 (20): 3519–27. doi:10.1242/jcs.112.20.3519. PMID 10504300.
• van Schaik RH, Wierikx CD, Timmerman MA, Oomen MH, van Weerden WM, van der Kwast TH, van Steenbrugge GJ, de Jong FH (2000). "Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues". Br. J. Cancer. 82 (1): 112–7. doi:10.1054/bjoc.1999.0886. PMC 2363208. PMID 10638976.
• Shoji H, Tsuchida K, Kishi H, Yamakawa N, Matsuzaki T, Liu Z, Nakamura T, Sugino H (2000). "Identification and characterization of a PDZ protein that interacts with activin type II receptors". J. Biol. Chem. 275 (8): 5485–92. doi:10.1074/jbc.275.8.5485. PMID 10681527.

• Biology

• Genes on human chromosome 2
• GS domain
• TS domain
• S/T domain
• Human proteins
• EC 2.7.11